In the past 6 days I have experienced one of my professional highs points as which may have triggered some raw emotions. On 07Sep10, we received unanimous FDA Advisory Committee vote in favor of our new antibiotic, ceftaroline fosamil. We presented to the AdCom our community acquired-pneumonia and complicated skin and skin structure infection studies. This is one of the last major hurdles in the review of our drug. We anticipate approval late this year. I was sitting in the front row during the meeting in Maryland. After the votes, I began to cry tears of joy and relief. The company was founded five years ago with the singular purpose of developing ceftaroline. I had joined four years ago to drive the pivotal studies which were presented. While I contributed to other successful drugs, this one I take great pride.
During my long and late flight home, I found my self crying at the thought that I would not be able to share this moment with Alicia. She and I had often talked about drug development and our drug. My mind began to create what may have been Alicia’s last steps and her fall. Recalling what the coroner had put forth has the likely course of events. I began to imagine what she may have felt... how scared she must have been. I spiraled with these thoughts for what seemed like a long time. I snapped back to the present when the cabin attendant asked if I needed something to drink.
I suspect I will continue to have these ‘gifts’. I miss her terribly.
No comments:
Post a Comment